Micronutrients in Health and Disease: References

1. Bisse E, Epting T, Beil A, Lindinger G, Lang H, Wieland H. Reference values for serum silicon in adults. Anal Biochem. 2005;337:130–135.

2. Srivastava AK, Mehdi MZ. Insulinomimetic and anti–diabetic effects of vanadium compounds. Diabet Med. 2005;22:2–13.

3. Ames BN, Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer. 2002;2:694–704.

4. Corman LC. Effects of specific nutrients on the immune response. Selected clinical applications. Med Clin North Am. 1985;69:759–791.

5. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999;19:357–377.

6. Hampl JS, Taylor CA, Johnston CS. Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994.
Am J Public Health. 2004;94:870–875.

7. Mayland CR, Bennett MI, Vitamin C deficiency in cancer patients. Palliat Med. 2005;19:17–20.

8. Paillaud E, Merlier I, Dupeyron C, Scherman E, Poupon J, Bories PN. Oral candidiasis and nutritional deficiencies in elderly hospitalised patients. Br J Nutr. 2004;92:861–867.

9. Levin NA, Greer KE. Scurvy in an unrepentant carnivore. Cutis. 2000;66:39–44.

10. Gartner LM, Greer FR. Section on Breastfeeding and Committee on Nutrition. American Academy of Pediatrics. Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake. Pediatrics. 2003;111(pt 1):908–910.

11. Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr. 2004;80(suppl 6):1710S–1716S.

12. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79:362–371.

13. Brown RO, Dickerson RN. Drug–nutrient interactions. Am J Manag Care. 1999;5:345–352.

14. Giovannucci E, Liu Y, Stampfer MJ, Willett WC. A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:203–210.

15. Heaney RP. Barriers to optimizing vitamin D3 intake for the elderly. J Nutr. 2006;136:1123–1125.

16. Centers for Disease Control and Prevention. Iron Deficiency–United States, 1999–2000. MMWR. 2002;51:897–899.  

17. Cuervo LG, Mahomed K. Treatments for iron deficiency anaemia in pregnancy.
Cochrane Database Syst Rev. 2001;CD003094.

18. Fuchs J, Podda M, Packer L, Kaufmann R. Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes. Toxicology. 2002;180:169–181.

19. Beutler E.The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood. 2003;101:3347–3350.

20. Lauffer RB, ed. Iron and Human Diseases. Boca Raton, FL: CRC; 1992.

21. Fleming DJ, Tucker Kl, Jacques PF, Dallal GE, Wilson PW, Wood RJ. Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort. Am J Clin Nutr. 2002;76:1375–1384.  

22. Newmark HL, Heaney RP, Lachance PA. Should calcium and vitamin D be added to the current enrichment program for cereal–grain products? Am J Clin Nutr. 2004;80:264–270.

23. Lanou AJ, Berkow SE, Barnard ND. Calcium, dairy products, and bone health in children and young adults: a reevaluation of the evidence. Pediatrics. 2005;115:736–743.

24. Feskanich D, Willett WC, Stampfer MJ, Colditz GA. Milk, dietary calcium, and bone fractures in women: a 12–year prospective study. Am J Public Health. 1997;87:992–997.

25. Institute of Medicine. Dietary Reference Intakes for Calcium, Magnesium, Vitamin D, and Fluoride. Washington, D.C.: National Academy Press; 2000:190–249.

26. Agus ZS. Hypomagnesemia. J Am Soc Nephrol.1999;10:1616–1622.

27. King DE, Mainous AG III, Geesey ME, Woolson RF. Dietary magnesium and C–reactive protein levels. J Am Coll Nutr. 2005;24:166–171.  

28. Huerta MG, Roemmich JN, Kingston ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28:1175–1181.

29. de Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998;21:682–686.

30. U.S. Preventive Services Task Force. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Ann Intern Med. 2003;139:51–55.

31. Cao G, Russell RM, Lischner N, Prior RL. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr. 1998;128:2383–2390.

32. Michels KB, Wolk A. A prospective study of variety of healthy foods and mortality in women. Int J Epidemiol. 2002;31:847–854.

33. Kris–Etherton PM, Hecker KD, Bonanome A, et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002;113(suppl 9B):71S–88S.

34. Fraser GE. Associations between diet and cancer, ischemic heart disease, and all–cause mortality in non–Hispanic white California Seventh–day Adventists. Am J Clin Nutr. 1999;70(suppl 3):532S–538S.

35. Bergheim I, Parlesak A, Dierks C, Bode JC, Bode C. Nutritional deficiencies in German middle–class male alcohol consumers: relation to dietary intake and severity of liver disease. Eur J Clin Nutr. 2003;57:431–438.

36. Gueguen S, Pirollet P, Leroy P, et al.Changes in serum retinol, alpha–tocopherol, vitamin C, carotenoids, zinc and selenium after micronutrient supplementation during alcohol rehabilitation. J Am Coll Nutr. 2003;22:303–310.

37. Thomson AD, Cook CCH, Touquet R, Henry JA. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the Accident and Emergency Department. Alcohol and Alcoholism. 2002;37:513–521.

38. Stolzenberg–Solomon RZ, Change SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2006;83:895–904.

39. Akikusa JD, Garrick D, Nash MC. Scurvy: forgotten but not gone. J Paediatr Child Health. 2003;39:75–77.

40. Davey GK, Spencer EA, Appleby PN, Allen NE, Knox KH, Key TJ. EPIC–Oxford: lifestyle characteristics and nutrient intakes in a cohort of 33,883 meat–eaters and 31,546 non meat–eaters in the UK. Public Health Nutr. 2003;6:259–269.  

41. Thane CW, Bates CJ. Dietary intakes and nutrient status of vegetarian preschool children from a British national survey. J Hum Nutr Diet. 2000;13:149–162.

42. Alexander H, Lockwood LP, Harris MA, Melby CL. Risk factors for cardiovascular disease and diabetes in two groups of Hispanic Americans with differing dietary habits. J Am Coll Nutr. 1999;18:127–136.

43. Koebnick C, Heins UA, Hoffman I, Dagnelie PC, Leitzmann C. Folate status during pregnancy in women is improved by long–term high vegetable intake compared with the average western diet. J Nutr. 2001;131:733–739.

44. Ma J, Hampl JS, Betts NM. Antioxidant intakes and smoking status: data from the continuing survey of food intakes by individuals 1994–1996. Am J Clin Nutr. 2000;71:774–780.

45. Dietrich M, Block G, Norkus EP, et al. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma–tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr. 2003;77:160–166.

46. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA. 2002;287:3116–3126.

47. Liu T, Howard RM, Mancini AJ, et al. Kwashiorkor in the United States: fad diets, perceived and true milk allergy, and nutritional ignorance. Arch Dermatol. 2001;137:630–636.

48. Greene–Finestone LS, Campbell MK, Evers SE, Gutmanis IA.  Adolescents' low–carbohydrate–density diets are related to poorer dietary intakes. J Am Diet Assoc. 2005;105:1783–1788.

49. Turner–McGrievy GM, Barnard ND, Scialli AR, Lanou AJ. Effects of a low–fat, vegan diet and a Step II diet on macro– and micronutrient intakes in overweight, postmenopausal women. Nutrition. 2004;20:738–746.

50. Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA. 2002;287:3127–3129.

51. Seymons K, De Moor A, De Raeve H, Lambert J. Dermatologic signs of biotin deficiency leading to the diagnosis of multiple carboxylase deficiency. Pediatr Dermatol. 2004;21:231–235.

52. Grillo E, da Silva RJ, Barbato JH Jr. Pyridoxine–dependent seizures responding to extremely low–dose pyridoxine. Dev Med Child Neurol. 2001;43:413–415.

53. Lewis DP, Van Dyke DC, Stumbo PJ, Berg MJ. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate. Ann Pharmacother. 1998;32:802–817.

54. Tumer L, Serdaroglu A, Hasanoglu A, Biberoglu G, Aksoy E. Plasma homocysteine and lipoprotein (a) levels as risk factors for atherosclerotic vascular disease in epileptic children taking anticonvulsants. Acta Paediatr. 2002;91:923–926.

55. Huemer M, Ausserer B, Graninger G, et al. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia. 2005;46:1677–1683.

56. Apeland T, Mansoor MA, Pentieva K, McNulty H, Seljieflot I, Strandjord RE. The effect of B–vitamins on hyperhomocysteinemia in patients on antiepileptic drugs. Epilepsy Res. 2002;51:237–247.

57. Endresen GK, Husby G. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol. 2001;30:129–134.

58. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum. 2002;46:328–346.

59. Wolters M, Strohle A, Hahn A. Cobalamin: a critical vitamin in the elderly. Prev Med. 2004;39:1256–1266.

60. Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;334:574–579.

61. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care.2000;23:1227–1231.

62. Sica D. Antihypertensive therapy and its effects on potassium homeostasis. J Clin Hypertens (Greenwich). 2006;8:67–73.

63. Lajer H, Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev. 1999;25:47–58.

64. Maalouf NM, Heller HJ, Odvina CV, Kim PJ, Sakhae K. Bisphosphonate–induced hypocalcemia: report of 3 cases and review of literature. Endocr Pract. 2006;12:48–53.

65. Aslam A, Misbah SA, Talbot K, Chapel H. Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency. Clin Immunol. 2004;112:24–29.

66. Jacobs DR Jr, Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: a framework for food synergy. Am J Clin Nutr. 2003;78(suppl 3):508S–513S.

67. Halliwell B, Rafter J, Jenner A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr. 2005;81(1 Suppl):268S–276S.

68. Schaffer S, Muller WE, Eckert GP. Tocotrienols: constitutional effects in aging and disease. J Nutr 2005; 135(2):151–154.

69. Anon. Lutein and zeaxanthin. Monograph. Alt Med Rev. 2005;10:128–135.

70. Vu HT, Robman L, McCarty CA, Taylor HR, Hodge A. Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project. Br J Ophthalmol. 2006;90:389–390.